9-17135300-C-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_017738.4(CNTLN):āc.235C>Gā(p.Leu79Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00022 in 1,600,958 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_017738.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CNTLN | NM_017738.4 | c.235C>G | p.Leu79Val | missense_variant | 1/26 | ENST00000380647.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CNTLN | ENST00000380647.8 | c.235C>G | p.Leu79Val | missense_variant | 1/26 | 1 | NM_017738.4 | P1 | |
CNTLN | ENST00000380641.4 | c.235C>G | p.Leu79Val | missense_variant | 1/7 | 2 | |||
CNTLN | ENST00000484374.1 | n.319C>G | non_coding_transcript_exon_variant | 1/3 | 2 |
Frequencies
GnomAD3 genomes AF: 0.000237 AC: 36AN: 152152Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000199 AC: 44AN: 221108Hom.: 0 AF XY: 0.000134 AC XY: 16AN XY: 119418
GnomAD4 exome AF: 0.000218 AC: 316AN: 1448690Hom.: 0 Cov.: 34 AF XY: 0.000199 AC XY: 143AN XY: 719012
GnomAD4 genome AF: 0.000236 AC: 36AN: 152268Hom.: 0 Cov.: 33 AF XY: 0.000215 AC XY: 16AN XY: 74442
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 10, 2022 | The c.235C>G (p.L79V) alteration is located in exon 1 (coding exon 1) of the CNTLN gene. This alteration results from a C to G substitution at nucleotide position 235, causing the leucine (L) at amino acid position 79 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at